1. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
   Jeong-Yeon Lee et al, 2016, Cell Mol Life Sci CrossRef
2. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A
   Susanna Ambrosio et al, 2017, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
3. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
   Nicolas Skrypek et al, 2017, Trends in Genetics CrossRef
4. Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail
   Lei Wu et al, 2016, Biomedicine & Pharmacotherapy CrossRef
5. Effect of suberoylanilide hydroxamic acid (SAHA) on breast cancer cells within a tumor–stroma microfluidic model
   N. Peela et al, 2017, Integr. Biol. CrossRef
6. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer
   Abigail B. McLeod et al, 2017, Prostate CrossRef
7. Epigenetic alterations in gastric cancer (Review)
   DU-GUAN FU, 2015 CrossRef
8. Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma
   Ayako Kanamoto et al, 2016 CrossRef
9. Optogenetics in cancer drug discovery
   Michał Kiełbus et al, 2018, Expert Opinion on Drug Discovery CrossRef
10. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells
    Lingling Yang et al, 2018, Experimental Cell Research CrossRef
11. Histone Deacetylase Functions in Epidermal Development, Homeostasis and Cancer
    Donna M. Brennan-Crispi et al, 2018 CrossRef
12. HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation
    Marie Friedrich et al, 2019, Mucosal Immunol CrossRef
13. Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells.
    Anna Wawruszak et al, 2019, Cancers (Basel) CrossRef
14. Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α
    Simona Citro et al, 2019, Br J Cancer CrossRef
15. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
    Margarite D. Matossian et al, 2019, BMC Cancer CrossRef
16. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
    Zhihua Shen et al, 2019, BMC Cancer CrossRef
17. Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms
    Saleheh Rezapour et al, 2019, J Cell Physiol CrossRef
18. Analysis of Histone Deacetylase-Dependent Effects on Cell Migration Using the Stripe Assay
    Sonja Mertsch et al, 2017 CrossRef
19. Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells
    Hehe Li et al, 2019, Cell Biosci CrossRef
20. Trichostatin A inhibits phenotypic transition and induces apoptosis of the TAF-treated normal colonic epithelial cells through regulation of TGF-β pathway
    Chao Huang et al, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
21. Metabolic Plasticity and Epithelial-Mesenchymal Transition
    Timothy M. Thomson et al, 2019, JCM CrossRef
22. Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail
    Jutao Feng et al, 2015, Cell Adhesion & Migration CrossRef
23. Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells
    Sin Y. Choi et al, 2016, J. Cell. Mol. Med. CrossRef
24. SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours
    Laura M. López‐Sánchez et al, 2019, J Cell Mol Med CrossRef
25. Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1
    Siyuan Zhang et al, 2019, European Journal of Pharmacology CrossRef
26. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
    Sugandha Bhatia et al, 2017 CrossRef
27. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells
    Mehrnaz Jahani et al, 2020, J Gastrointest Canc CrossRef
28. Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
    Bo Dong et al, 2020, Front. Pharmacol. CrossRef
29. Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity
    Vanessa Pereira et al, 2021, Mol Neurobiol CrossRef
30. Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
    Qiu-Luo Liu et al, 2021, Front. Oncol. CrossRef
31. Trichostatin A promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4/ERK1/2‐dependent pathway
    Danhui Liu et al, 2021, Cancer Med CrossRef
32. Preparation of Mitochondria‐ and Epigenetics‐Targeting Nanoparticles for Suppression of Cancer Metastasis
    Takeru Yamazaki et al, 2021, Part. Part. Syst. Charact. CrossRef
33. Silver Nanoparticles Modulate the Epithelial-to-Mesenchymal Transition in Estrogen-Dependent Breast Cancer Cells In Vitro
    Michał Rakowski et al, 2021, IJMS CrossRef
34. Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer
    Qiongwei Wu et al, 2021, Oncol Lett CrossRef
35. HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells.
    Thais Oliveira et al, 2021, Redox Biol CrossRef
36. Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia
    Vivek Bora et al, 2021, Can. J. Physiol. Pharmacol. CrossRef
37. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
    Sheng-Mao Wu et al, 2022, Cell Biol Toxicol CrossRef
38. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    Xue-Song Xiang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
39. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target
    Sven Jonckheere et al, 2022, Cells Tissues Organs CrossRef
40. Regulation of epithelial-mesenchymal transition by protein lysine acetylation
    Fanyun Kong et al, 2022, Cell Commun Signal CrossRef
41. Epigenetic therapies: histone deacetylases
    Christophe Blanquart, 2023 CrossRef
42. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells.
    Amirhosein Maharati et al, 2023, Cell Commun Signal CrossRef
43. EMT-induced immune evasion: connecting the dots from mechanisms to therapy
    Sikiru O. Imodoye et al, 2023, Clin Exp Med CrossRef
44. Gαi2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration
    Silvia Caggia et al, 2024, Cancers CrossRef
45. Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways
    Hsueh-Yun Lee et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
46. Design and evaluation of nanoscale materials with programmed responsivity towards epigenetic enzymes
    Priyanka Ray et al, 2024, J. Mater. Chem. B CrossRef
47. Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis.
    Ewa Nowak et al, 2021, Cells CrossRef